VOICE ONE:
This is SCIENCE IN THE NEWS, in VOA Special English. I'm Bob Doughty.
VOICE TWO:
And,
I'm Shirley Griffith. This week, we will tell about what is said to be
the largest study yet of a treatment for Parkinson's disease. We will
also tell about a study of young Americans and their use of social Web
sites on the Internet.
(MUSIC)
VOICE ONE:
Recently,
researchers in the United States studied the effectiveness of a
treatment called deep brain stimulation. It has been used for years to
treat patients with Parkinson's disease. The study found that the
physical condition of Parkinson's patients often improves after they
receive deep brain stimulation. But brain stimulation was also shown to
have more side effects than drug treatments.
Parkinson's
is a disease of the central nervous system. The disease affects between
five hundred thousand and one million five hundred thousand Americans.
Doctors confirm about sixty thousand new Parkinson's cases in the
United States each year. The disease affects a small area of cells in
the middle of the brain. The cells slowly lose their ability to produce
a chemical called dopamine.
The decrease in the
amount of dopamine can result in one or more of the general signs of
Parkinson's. These include shaking in the hands, arms and legs. They
also include muscle tightness and restricted movements. Another symptom
is difficulty keeping balanced while standing or walking. Medicine can
help patients. Yet it can become less effective as the disease
progresses.
VOICE TWO:
Deep
brain stimulation uses electricity to shock the brain in areas that
help send messages to the body. In Parkinson's patients, these areas of
the brain can become blocked. When this happens, the messages give
misinformation to the body.
Deep brain
stimulation begins by doctors drilling two small holes in the head of
the patient. Two thin, electrical wires are then placed in the brain.
They are connected under the skin to another wire that leads to a small
battery placed in the chest. The device supplies electricity.
Doctors
do not know exactly how the brain stimulation works to help patients
with Parkinson's. But experts believe the electrical current might help
activate nerve cells that are not working correctly.
VOICE ONE:
The
study involved two hundred fifty-five Parkinson's patients. It took
place at thirteen medical centers across the United States between May
of two thousand two and October of two thousand five. The patients kept
written records of their physical abilities.
The
Journal of the American Medical Association published results of the
study. They showed that patients who received deep brain stimulation
had better control of their symptoms than those who only took medicine.
In fact, the patients who had the treatment reported an average gain of
nearly five hours each day of good control of their symptoms. The
average gain was zero hours for the other group.
VOICE TWO:
Deep
brain stimulation is not the answer for all Parkinson's patients.
Doctors say it is best for patients whose medicines cause side effects
or are not working. The treatment is not new. It was first approved for
use in the United States in nineteen ninety-seven. However, its
effectiveness had never before been compared to that of medicines in a
large study.
In the United States, Parkinson's
patients can receive deep brain stimulation at about three hundred
medical centers. The treatment has been performed about forty thousand
times throughout the world.
But several
possible side effects make the treatment risky. The side effects
include pain in the head, problems speaking and slowed movement. One
patient who had the surgery died. However, in many cases, the
researchers found the side effects ended within six months. And, some
patients said the improvements they experienced were worth the risk.
VOICE ONE:
Deep
brain stimulation is also costly. It can cost as much as one hundred
fifty thousand dollars. In addition, the battery placed under the skin
may require a replacement. This means doctors need to perform another
operation.
The company that makes the device,
Medtronic, helped to pay for the study. Financial support also came
from the United States Department of Veterans Affairs and the National
Institute of Neurological Disorders and Stroke.
In
addition to people with Parkinson's, the treatment is also being tested
for patients with severe depression, lasting pain and epilepsy.
(MUSIC)